Paper32695103
Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.
Comi M and 9 others. Front Immunol, 2020. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer. Papers, record 32695103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32695103
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dendritic Cells | Major topic |
| Genetic Vectors | Major topic |
| Immune Tolerance | Major topic |
| Interleukin-10 | Major topic |
| Lentivirus | Major topic |
| Transduction, Genetic | Major topic |
| Animals | |
| Female | |
| Gene Expression | |
| Humans | |
| Immunophenotyping | |
| Mice | |
| Monocytes | |
| T-Lymphocytes |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 33828568 | Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer. | https://conductscience.org/library/papers/33828568 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20140891 | Dendritic cells lentivirally engineered to overexpress interleukin-10 inhibit contact hypersensitivity responses, despite their partial activation induced by transduction-associated physical stress. | J Gene Med | 2010 | https://conductscience.org/library/papers/20140891 | PubMed |
| 2 | 31130302 | Regulatory dendritic cells for human organ transplantation. | Transplant Rev (Orlando) | 2019 | https://conductscience.org/library/papers/31130302 | PubMed |
| 3 | 25567537 | Vpx-containing dendritic cell vaccine induces CTLs and reactivates latent HIV-1 in vitro. | Gene Ther | 2015 | https://conductscience.org/library/papers/25567537 | PubMed |
| 4 | 29686676 | Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/29686676 | PubMed |
| 5 | 30357490 | Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation. | Cancer Immunol Immunother | 2019 | https://conductscience.org/library/papers/30357490 | PubMed |
| 6 | 24292363 | Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. | Nat Immunol | 2014 | https://conductscience.org/library/papers/24292363 | PubMed |
| 7 | 22895508 | Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. | Gene Ther | 2013 | https://conductscience.org/library/papers/22895508 | PubMed |
| 8 | 29705245 | Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis. | J Allergy Clin Immunol | 2018 | https://conductscience.org/library/papers/29705245 | PubMed |
| 9 | 16418327 | Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. | Blood | 2006 | https://conductscience.org/library/papers/16418327 | PubMed |
| 10 | 8610423 | Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin. | Transplantation | 1996 | https://conductscience.org/library/papers/8610423 | PubMed |
| 11 | 8525540 | Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. | Transplantation | 1995 | https://conductscience.org/library/papers/8525540 | PubMed |
| 12 | 11895781 | CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. | Blood | 2002 | https://conductscience.org/library/papers/11895781 | PubMed |
| 13 | 27456849 | Dendritic cells as gatekeepers of tolerance. | Semin Immunopathol | 2017 | https://conductscience.org/library/papers/27456849 | PubMed |
| 14 | 28521905 | Harnessing the properties of dendritic cells in the pursuit of immunological tolerance. | Biomed J | 2017 | https://conductscience.org/library/papers/28521905 | PubMed |
| 15 | 29520275 | Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand? | Front Immunol | 2018 | https://conductscience.org/library/papers/29520275 | PubMed |
| 16 | 29616018 | Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. | Front Immunol | 2018 | https://conductscience.org/library/papers/29616018 | PubMed |
| 17 | 18568076 | Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18568076 | PubMed |
| 18 | 21804023 | Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. | J Immunol | 2011 | https://conductscience.org/library/papers/21804023 | PubMed |
| 19 | 27547767 | Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews. | J Immunol Res | 2016 | https://conductscience.org/library/papers/27547767 | PubMed |
| 20 | 9366401 | Induction of tolerance by IL-10-treated dendritic cells. | J Immunol | 1997 | https://conductscience.org/library/papers/9366401 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42527763 | Immune cells in liver transplantation: Dual roles, mechanistic insights, and targeted therapeutic strategies. | Immunol Res | 2026 | https://conductscience.org/library/papers/42527763 | PubMed |
| 42317359 | Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317359 | PubMed |
| 41657312 | Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes. | JCI Insight | 2026 | https://conductscience.org/library/papers/41657312 | PubMed |
| 41270166 | Antigen-specific B cell response regulation by IL-10-producing tolerogenic dendritic cells. | Sci Adv | 2025 | https://conductscience.org/library/papers/41270166 | PubMed |
| 41210169 | Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41210169 | PubMed |
| 40426300 | Advances in Regulatory Cell Therapy for Type 1 Diabetes: Emerging Strategies and Future Directions. | Eur J Immunol | 2025 | https://conductscience.org/library/papers/40426300 | PubMed |
| 39266465 | Leveraging current insights on IL-10-producing dendritic cells for developing effective immunotherapeutic approaches. | FEBS Lett | 2025 | https://conductscience.org/library/papers/39266465 | PubMed |
| 37298076 | IL-10-Engineered Dendritic Cells Modulate Allogeneic CD8+ T Cell Responses. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298076 | PubMed |
| 34539674 | 24th "Nantes Actualités en Transplantation" and 4th "LabEx Immunotherapy-Graft-Oncology" NAT and IGO Joint Meeting "New Horizons in Immunotherapy". | Front Immunol | 2021 | https://conductscience.org/library/papers/34539674 | PubMed |
| 34445143 | Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445143 | PubMed |
| 34360736 | Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360736 | PubMed |
| 34065421 | Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34065421 | PubMed |
| 33777019 | Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease. | Front Immunol | 2021 | https://conductscience.org/library/papers/33777019 | PubMed |
| 33708227 | Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions. | Front Immunol | 2021 | https://conductscience.org/library/papers/33708227 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32695103
GET https://conductscience.org/api/papers/v1/32695103/references?page=2